Table 1 Summary of GPC3 immunoreactivity.
From: Expression of glypican 3 in placental site trophoblastic tumor
| Â | 0 (< 5% cells stained) | 1+ (5-10% cells stained) | 2+ (11-50% cells stained) | 3+ (> 50% cells stained) | Mean Intensity |
|---|---|---|---|---|---|
Placental site trophoblastic tumor (n = 15) | 3 (20%) | 3 (20%) | 6 (40%) | 3 (20%) | 1.3 |
Placental site nodule (n = 2) | 0 | 1 (50%) | 1 (50%) | 0 | 1.5 |
Cervical squamous cell carcinoma (n = 7) | 4 (57%) | 2 (29%) | 1 (14%) | 0 | 0.7 |
Endometrial adenocarcinoma (n = 11) | 11 (100%) | 0 | 0 | 0 | 0 |
Uterine leiomyoma (n = 1) | 1 (100%) | 0 | 0 | 0 | 0 |
Leiomyosarcoma (n = 1) | 1 (100%) | 0 | 0 | 0 | 0 |